Section Arrow
IPSC.NASDAQ
- Century Therapeutics
(Financial Status)
Quotes are at least 15-min delayed:2025/06/02 03:51 EDT
Last
 0.525
-0.032 (-5.75%)
Day High 
0.567 
Prev. Close
0.557 
1-M High
0.635 
Volume 
1.78M 
Bid
--
Ask
--
Day Low
0.525 
Open
0.56 
1-M Low
0.475 
Market Cap 
47.99M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.56 
20-SMA 0.55 
50-SMA 0.52 
52-W High 3.46 
52-W Low 0.3418 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.27/-1.56
Enterprise Value
96.95M
Balance Sheet
Book Value Per Share
2.79
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.59M
Operating Revenue Per Share
0.05
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
INABIN8bio0.1446-0.0088-5.74%-- 
BLRXBioLineRx Ltd5.18+1.3891+36.64%-- 
IMNNImunon2.45+0.46+23.12%-- 
NCNANuCana plc0.03525-0.00175-4.73%-- 
MRNAModerna26.58-0.35-1.30%-- 
Quotes are at least 15-min delayed:2025/06/02 03:51 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.